2018 Women and Lung Cancer Research and Preventive Services Act 

Priority focus on accelerated research and preventive screening services for women impacted by lung cancer was announced by Congress on January 30, 2018 with the reintroduction of the Women and Lung Cancer Research and Preventive Services Act into both the Senate (S. 2358) and the House (H.R. 4897). The legislation was first introduced in 2016.

Currently, lung cancer is the leading cause of cancer death among women. In the United States, an average of 193 women die each day from lung cancer, one every seven minutes. Women make up two-thirds of never smokers diagnosed with lung cancer.

Thank you to those members of Congress who have co-sponsored the legislation.

The legislation brings a targeted approach to close knowledge gaps and advance research to address the disparate impact of lung cancer on women. The legislation also advances preventive screening and a coordinated awareness program to educate the public on the impact of lung cancer and importance of early detection.

“This legislation allows us to learn more about how lung cancer behaves in women at a time of heightened awareness about women’s health and well-being. By unlocking answers to this question, we will be better positioned to make life-saving gains in early detection and treatment that will benefit women and our entire community.”
– Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance

Take Action

For additional information on getting involved in advocacy efforts, please contact us at policy@lungcanceralliance.org.

Additional Resources

Watch Elridge Proctor, Lung Cancer Alliance’s Director of Health Policy, discuss the Women and Lung Cancer Research and Preventive Services Act on The Bonnie J. Addario Lung Cancer Foundation The Living Room from March 20, 2018 (:57 – 1:18).